Dataset Information

Change point estimation in monitoring survival time.

ABSTRACT: Precise identification of the time when a change in a hospital outcome has occurred enables clinical experts to search for a potential special cause more effectively. In this paper, we develop change point estimation methods for survival time of a clinical procedure in the presence of patient mix in a Bayesian framework. We apply Bayesian hierarchical models to formulate the change point where there exists a step change in the mean survival time of patients who underwent cardiac surgery. The data are right censored since the monitoring is conducted over a limited follow-up period. We capture the effect of risk factors prior to the surgery using a Weibull accelerated failure time regression model. Markov Chain Monte Carlo is used to obtain posterior distributions of the change point parameters including location and magnitude of changes and also corresponding probabilistic intervals and inferences. The performance of the Bayesian estimator is investigated through simulations and the result shows that precise estimates can be obtained when they are used in conjunction with the risk-adjusted survival time CUSUM control charts for different magnitude scenarios. The proposed estimator shows a better performance where a longer follow-up period, censoring time, is applied. In comparison with the alternative built-in CUSUM estimator, more accurate and precise estimates are obtained by the Bayesian estimator. These superiorities are enhanced when probability quantification, flexibility and generalizability of the Bayesian change point detection model are also considered.

SUBMITTER: Assareh H

PROVIDER: S-EPMC3306432 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Change point estimation in monitoring survival time.

Assareh Hassan H Mengersen Kerrie K

PloS one 20120316 3

Precise identification of the time when a change in a hospital outcome has occurred enables clinical experts to search for a potential special cause more effectively. In this paper, we develop change point estimation methods for survival time of a clinical procedure in the presence of patient mix in a Bayesian framework. We apply Bayesian hierarchical models to formulate the change point where there exists a step change in the mean survival time of patients who underwent cardiac surgery. The dat ...[more]

PMID: 22438969

Similar Datasets

Project description:Increasing awareness of the issue of deforestation and degradation in the tropics has resulted in efforts to monitor forest resources in tropical countries. Advances in satellite-based remote sensing and ground-based technologies have allowed for monitoring of forests with high spatial, temporal and thematic detail. Despite these advances, there is a need to engage communities in monitoring activities and include these stakeholders in national forest monitoring systems. In this study, we analyzed activity data (deforestation and forest degradation) collected by local forest experts over a 3-year period in an Afro-montane forest area in southwestern Ethiopia and corresponding Landsat Time Series (LTS). Local expert data included forest change attributes, geo-location and photo evidence recorded using mobile phones with integrated GPS and photo capabilities. We also assembled LTS using all available data from all spectral bands and a suite of additional indices and temporal metrics based on time series trajectory analysis. We predicted deforestation, degradation or stable forests using random forest models trained with data from local experts and LTS spectral-temporal metrics as model covariates. Resulting models predicted deforestation and degradation with an out of bag (OOB) error estimate of 29% overall, and 26% and 31% for the deforestation and degradation classes, respectively. By dividing the local expert data into training and operational phases corresponding to local monitoring activities, we found that forest change models improved as more local expert data were used. Finally, we produced maps of deforestation and degradation using the most important spectral bands. The results in this study represent some of the first to combine local expert based forest change data and dense LTS, demonstrating the complementary value of both continuous data streams. Our results underpin the utility of both datasets and provide a useful foundation for integrated forest monitoring systems relying on data streams from diverse sources.

Project description:IntroductionEstimation of accurate time-integrated activity coefficients (TIACs) and radiation absorbed doses (ADs) is desirable for treatment planning in peptide-receptor radionuclide therapy (PRRT). This study aimed to investigate the accuracy of a simplified dosimetry using a physiologically-based pharmacokinetic (PBPK) model, a nonlinear mixed effect (NLME) model, and single-time-point imaging to calculate the TIACs and ADs of 90Y-DOTATATE in various organs of dosimetric interest and tumors.Materials & methodsBiokinetic data of 111In-DOTATATE in tumors, kidneys, liver, spleen, and whole body were obtained from eight patients using planar scintigraphic imaging at T1 = (2.9 ± 0.6), T2 = (4.6 ± 0.4), T3 = (22.8 ± 1.6), T4 = (46.7 ± 1.7) and T5 = (70.9 ± 1.0) h post injection. Serum activity concentration was measured at 5 and 15 min; 0.5, 1, 2, and 4 h; and 1, 2, and 3 d p.i.. A published PBPK model for PRRT, NLME, and a single-time-point imaging datum at different time points were used to calculate TIACs in tumors, kidneys, liver, spleen, whole body, and serum. Relative deviations (RDs) (median [min, max]) between the calculated TIACs from single-time-point imaging were compared to the TIACs calculated from the all-time-points fit. The root mean square error (RMSE) of the difference between the computed ADs from the single-time-point imaging and reference ADs from the all-time point fittings were analyzed. A joint root mean square error RMSEjoint of the ADs was calculated with the RSME from both the tumor and kidneys to sort the time points concerning accurate results for the kidneys and tumor dosimetry. The calculations of TIACs and ADs from the single-time-point dosimetry were repeated using the sum of exponentials (SOE) approach introduced in the literature. The RDs and the RSME of the PBPK approach in our study were compared to the SOE approach.ResultsUsing the PBPK and NLME models and the biokinetic measurements resulted in a good fit based on visual inspection of the fitted curves and the coefficient of variation CV of the fitted parameters (<50%). T4 was identified being the time point with a relatively low median and range of TIACs RDs, i.e., 5 [1, 21]% and 2 [-15, 21]% for kidneys and tumors, respectively. T4 was found to be the time point with the lowest joint root mean square error RMSEjoint of the ADs. Based on the RD and RMSE, our results show a similar performance as the SOE and NLME model approach.SummaryIn this study, we introduced a simplified calculation of TIACs/ADs using a PBPK model, an NLME model, and a single-time-point measurement. Our results suggest a single measurement might be used to calculate TIACs/ADs in the kidneys and tumors during PRRT.

Dataset Information

Change point estimation in monitoring survival time.

Publications

Change point estimation in monitoring survival time.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets